Vitamin D Receptor Polymorphisms in a Spanish Cohort of Parkinson's Disease Patients
Genetic Testing and Molecular Biomarkers · 2024
DOI: 10.1089/gtmb.2023.0344 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetic Testing and Molecular Biomarkers, 2024. Verfasst von Saray Canales-Cortés und 6 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Universidad de Extremadura, Cáceres, Spain. Hauptthemen laut MEDLINE: Imidoesters, Parkinson Disease, Receptors, Calcitriol. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Background
Vitamin D receptor (VDR) is a nuclear hormone receptor widely expressed in the substantia nigra. Its association with an increased risk of Parkinson's disease (PD) is based on vitamin D deficiency and/or different polymorphisms in its gene receptor. This fact has been demonstrated by several case-control studies. Materials and Methods: Consequently, we investigated the association between VDR ApaI, BsmI, FokI, and TaqI gene polymorphisms and PD in a Spanish cohort that included 54 cases and 17 healthy controls. The detection of single nucleotide polymorphisms (SNPs) was performed using a polymerase chain reaction-restriction fragment length polymorphism.
Results
Our data indicate that the SNPs were not associated with the age of onset of PD, nor with the occurrence of motor symptoms. However, only BsmI polymorphism was significantly associated with PD in this Spanish cohort. In fact, BsmI genotype was five times higher among PD patients than among controls, and the A allele was considered as a genetic risk for PD. Additionally, the combination of FokI and BsmI polymorphisms was significantly associated with PD and could represent a risk factor.
Conclusion
We conclude that ApaI, TaqI, and FokI polymorphisms were not associated with PD, but BsmI could be a risk factor for PD in this randomized population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Universidad de Extremadura, Cáceres, Spain.
- Instituto Universitario de Investigación Biosanitaria de Extremadura (INUBE), Cáceres, Spain.
- Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas-Instituto de Salud Carloss III (CIBER-CIBERNED-ISCIII), Madrid, Spain.
- Pharmaceutical Technologic, Medical Sciences Department, Albacete School of Pharmacy, University of Castilla-La Mancha, Albacete, Spain.
- Pharmacology, Medical Sciences Department, Albacete School of Medicine, University of Castilla-La Mancha, Albacete, Spain.
- Complejo Hospitalario Universitario de Cáceres, Cáceres, Spain.
ORCID-Profile: José M Fuentes, Sokhna M S Yakhine-Diop
Zitieren
APA
Canales-Cortés, S., Rodríguez-Arribas, M., Galindo, M. F., Jordan, J., Casado-Naranjo, I., Fuentes, J. M., & Yakhine-Diop, S. M. S. (2024). Vitamin D Receptor Polymorphisms in a Spanish Cohort of Parkinson's Disease Patients. Genetic Testing and Molecular Biomarkers. https://doi.org/10.1089/gtmb.2023.0344
Vancouver
Canales-Cortés S, Rodríguez-Arribas M, Galindo MF, Jordan J, Casado-Naranjo I, Fuentes JM, et al. Vitamin D Receptor Polymorphisms in a Spanish Cohort of Parkinson's Disease Patients. Genetic Testing and Molecular Biomarkers. 2024. doi:10.1089/gtmb.2023.0344
BibTeX
@article{CanalesCorts2024,
author = {Canales-Cortés, Saray and Rodríguez-Arribas, Mario and Galindo, María F and Jordan, Joaquín and Casado-Naranjo, Ignacio and Fuentes, José M and Yakhine-Diop, Sokhna M S},
title = {Vitamin D Receptor Polymorphisms in a Spanish Cohort of Parkinson's Disease Patients},
journal = {Genetic Testing and Molecular Biomarkers},
year = {2024},
doi = {10.1089/gtmb.2023.0344}
}
EUVIMED